JC

Jto Clinical And Research Reports

JTO Clinical and Research Reports is the official open access journal of the International Association for the Study of Lung Cancer. It complements the Journal of Thoracic Oncology by offering a gold open access publication option and particularly publishes Phase I trials, well performed single-arm phase II trials, subset analyses of published trials, impactful retrospective studies, database analysis, large institutional series, high-quality case reports, region-specific clinical trials, subspecialty thoracic oncology studies, and selected high-quality meeting reports.

Looking to publish in Jto Clinical And Research Reports? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.

Try Livewrite Now
Subject Oncology, Respiratory System
Impact Factor 3.5
Quartile Q2
Open Access Type Open
eISSN 2666-3643
Invitation Only No
Cost Range Article Publishing Charge (APC): USD 2,000 (excluding taxes)

Submission Instructions

Jto Clinical And Research Reports accepts the following article types. Click on an article type to view submission instructions.

Original Articles

Cover Letter Cover Letter requirements are not specified.
Abstract Original Articles must include a structured abstract. The abstract must not exceed 250 words. The abstract must be structured. The abstract must use the headings Introduction or Hypothesis, Methods, Results, and Conclusions.
Manuscript The manuscript must contain 4,000 words of text. The manuscript must be organized under the headings Introduction, Materials and Methods, Results, and Discussion. The manuscript must include three to five keywords and, if generative AI or AI-assisted technologies were used in writing, a disclosure statement before the references under the heading 'Declaration of Generative AI and AI-assisted technologies in the writing process'.
References The manuscript may include up to 50 references. References must be cited with consecutive superscript Arabic numerals and listed in numbered order of appearance. Journal names in references must be abbreviated according to the List of Title Word Abbreviations.
Figures & Tables The manuscript may include up to 6 tables and/or figures. Figures must be submitted as separate files with captions provided separately, and tables must be submitted as editable text. Figures and tables must be numbered consecutively in the order they are cited in the text.
Reformat to Jto Clinical And Research Reports using Livewrite Premium

Review Articles

Cover Letter Cover Letter requirements are not specified.
Abstract A structured abstract is required. Abstract must not exceed 250 words. Abstract must be structured. Abstract must use the headings Introduction or Hypothesis, Methods, Results, and Conclusions.
Manuscript Manuscript must be no longer than 4000 words. Manuscript must be organized under the headings Introduction, Materials and Methods, Results, and Discussion. Manuscript must include three to five keywords and a Declaration of Generative AI and AI-assisted technologies in the writing process before the references if such tools were used.
References References must not exceed 75. References must be cited as consecutive superscript Arabic numerals and listed in the order of appearance in the text.
Figures & Tables The article may include up to 6 tables and/or figures. Figures must be submitted as separate files with captions provided separately, and tables must be submitted as editable text.
Reformat to Jto Clinical And Research Reports using Livewrite Premium

Brief Reports

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract is required for Brief Reports. Abstract must not exceed 250 words. Abstract must be structured. Abstract must use the headings Introduction or Hypothesis, Methods, Results, and Conclusions.
Manuscript Manuscript must not exceed 1500 words. Manuscript must be organized under the four main headings Introduction, Materials and Methods, Results, and Discussion, and the title must include "Brief Report:". Manuscript must include three to five keywords and a declaration of generative AI and AI-assisted technologies in the writing process before the references if such tools were used.
References References must not exceed 15. References must be cited as consecutive superscript Arabic numerals in the text and listed in numbered order of appearance, with journal names abbreviated according to the List of Title Word Abbreviations.
Figures & Tables Brief Reports may include up to 3 tables and/or figures. Figures must be submitted as separate files with captions provided separately, and tables must be submitted as editable text.
Reformat to Jto Clinical And Research Reports using Livewrite Premium

Case Reports

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract is required and may be structured or unstructured. Abstract must not exceed 250 words. Abstract may be structured or unstructured. Abstract must include an introduction on what is unique about the case and its contribution to the literature, the patient's main concerns and important clinical findings, the primary diagnoses interventions and outcomes, and a conclusion with one or more take-away lessons.
Manuscript Manuscript must be 1000 words or less. Manuscript must include Introduction, Case Presentation, Discussion, and Conclusion sections. Manuscript must include 2 to 5 keywords including "case report," a conflict of interest disclosure statement, a short acknowledgement section mentioning funding support if applicable, a timeline figure or table, and de-identified patient-specific case details covering history, findings, diagnostics, interventions, outcomes, follow-up, adherence or tolerability, adverse events, and discussion of strengths, limitations, relevant literature, and rationale for conclusions.
References References must not exceed 5. References must be cited in the text using consecutive superscript Arabic numerals and listed in numbered order of appearance.
Figures & Tables Figures and tables may total no more than 3. Each illustration must be submitted as a separate file and captions for illustrations must be provided separately. Case Reports should include images and or photographs supporting the case, and the required timeline must be presented as a figure or table.
Reformat to Jto Clinical And Research Reports using Livewrite Premium

Letters To The Editor

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract requirements are not specified.
Manuscript Letters to the Editor must contain no more than 500 words. Letters to the Editor must be short, concise communications commenting on a recently published article in the journal or on a controversial current issue of concern to the readership. Letters to the Editor must be accompanied by a statement of potential sources of conflict of interest.
References Letters to the Editor must contain no more than 5 references, including a reference to the article in question. References must be cited in the text as consecutive superscript Arabic numerals and listed in numerical order of appearance.
Figures & Tables Figures & Tables requirements are not specified.
Reformat to Jto Clinical And Research Reports using Livewrite Premium

Recent Publications

Trastuzumab Deruxtecan Induces Complete Pathological Response in Oligometastatic HER2-Mutant NSCLC: Case Report

Laurenz Nagl, Lena Horvath, Arno Amann, Lorenz Schreiner, Michael Günther, Herbert Maier, Johannes Kerschbaumer, Gerlig Widmann, Danijela Minasch, Lisa-Maria Rossetti, Katharina Kostenzer, Dominik Wolf, Florian Augustin, Andreas Pircher

10.1016/j.jtocrr.2026.101023
View Publication

Anakinra prophylaxis for recurrent severe ICANS associated with tarlatamab in small cell lung cancer: Case Report

David W. Shia, Suwicha Limvorasak, Karen L. Reckamp, Kamya Sankar

10.1016/j.jtocrr.2026.101025
View Publication

Clinical outcomes for patients who received both trastuzumab deruxtecan (T-DXd) and trastuzumab emtansine (T-DM1) for HER2-mutant non-small cell lung cancer

Daniel Reinhorn, Jonathan Kuten, Isabel Preeshagul, Juliana Eng, Kenneth Ng, Alexander Drilon, Jamie Chaft, Fernando C. Santini, Mark M. Awad

10.1016/j.jtocrr.2026.101024
View Publication

Clinical and Immunological Features of Primary Enteric-Type Thymic Adenocarcinomas: A Rare Variant of a Rare Cancer

Alisa K. Sivapiromrat, Meredith J. McAdams, Renee N. Donahue, Carolina Celades, Wiem Lassoued, Hana Bagheri, Elsa Bahiru, Shannon Swift, Christine Feierabend, Susan Sansone, Laercio DaSilva, Eva Szabo, Chen Zhao, Jeffrey Schlom, James L. Gulley, Arun Rajan

10.1016/j.jtocrr.2026.101019
View Publication

Comparative Treatment Outcomes Across Actionable Genomic Alterations in Non-Small Cell Lung Cancer: A Large Multicenter Real-World Study

Yasuhiro Kato, Nobuhiko Nishijima, Satoshi Takahashi, Yukari Shirakura, Miwako Omori, Maiko Asai, Aya Fukuizumi, Kakeru Hisakane, Shinji Nakamichi, Susumu Takeuchi, Akihiko Miyanaga, Yoshinobu Saito, Takashi Hirose, Yukio Hosomi, Kazuo Kasahara, Masahiro Seike, Tetsuya Okano

10.1016/j.jtocrr.2026.101020
View Publication

Frequently asked questions

How long does it take to publish?

9 days submission to first decision; 47 days submission to decision after review; 111 days submission to acceptance; 6 days acceptance to online publication.

Reformat to Jto Clinical And Research Reports using Livewrite Premium

What are the publication costs?

Article Publishing Charge (APC): USD 2,000 (excluding taxes).

Reformat to Jto Clinical And Research Reports using Livewrite Premium

Research Topics

Lung Cancer Treatments and Mutations Lung Cancer Research Studies Lung Cancer Diagnosis and Treatment Cancer Immunotherapy and Biomarkers Cancer Genomics and Diagnostics Colorectal Cancer Treatments and Studies Neuroendocrine Tumor Research Advances Gastric Cancer Management and Outcomes Radiomics and Machine Learning in Medical Imaging Occupational and environmental lung diseases Global Cancer Incidence and Screening HER2/EGFR in Cancer Research PI3K/AKT/mTOR signaling in cancer Pancreatic and Hepatic Oncology Research Myasthenia Gravis and Thymoma Genetic factors in colorectal cancer Brain Metastases and Treatment Pleural and Pulmonary Diseases Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis Chronic Lymphocytic Leukemia Research Cancer therapeutics and mechanisms Colorectal and Anal Carcinomas Peptidase Inhibition and Analysis Neuroblastoma Research and Treatments Esophageal Cancer Research and Treatment

Related Journals

LI
Lancet Infectious Diseases Elsevier BV
EC
European Clinical Respiratory Journal Taylor & Francis
B&
Biomedicine & Pharmacotherapy Elsevier BV
JO
Journal Of The American Society Of Echocardiography Elsevier BV
BP
Biological Psychiatry Elsevier BV
AI
Artificial Intelligence In Medicine Elsevier BV